Clinical Trial Update: The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of Dipeptidyl Peptidase-4 inhibition on growth hormone secretion in women with polycystic ovary syndrome; study completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Snippet

Sponsor: Vanderbilt University | Conditions: Polycystic Ovary Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2020-05-08